Low testosterone may increase the risk of aggressive prostate cancer progression during active surveillance. Learn more about the findings.

New research has found that low testosterone levels can cause extreme progression in high-grade prostate cancer. The study ...

Improved radiographic progression-free survival (rPFS) regardless of disease volume or metastatic presentation achieved with ...

A previous trial involving patients with metastatic prostate cancer that was resistant to androgen pathway modulation (formerly referred to as castration-resistant) showed that adding talazoparib ...

Primary results from the Phase II ARACOG (AFT-47) trial, a head-to-head randomized trial conducted by Alliance Foundation Trials LLC, showed that patients treated with NUBEQA® (darolutamide; n=55) ...

Participating in a Memorial Day commemoration, Joe Biden made his first public address since the announcement of his Stage 4 prostate cancer diagnosis at a Biden family event in his home state of ...

TeLuRide-005, a Phase 2 trial of EIK1001 in first-line patients with stage 4 NSCLC completed enrollment of both non-squamous and squamous cohorts ...

Updateddata across two dose levels of 200 mW/cm and 400 mW/cmin LA-PDAC trialshow71% (5/7) patients resected following VTP with a consistent and well-tolerated safety profile- ...

Immunome, Inc. , a biotechnology company committed to developing first-in-class and best-in-class targeted cancer therapies, today announced detailed efficacy and safety results from RINGSIDE, the ...

The 2026 SNMMI annual meeting featured a clinical diagnosis and therapy session and a presentation by Dr. Kiflom Gebreslassea discussing a longitudinal analysis of estimated glomerular filtration rate ...

Larry W. King, the former husband of Billie Jean King who partnered with her on the creation of the WTA Tour and the “Battle of the Sexes” tennis match, died Friday. He ...